Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-FR Version v6-FR
Language French French
Date Updated 2022-07-20 2020-08-11
Drug Identification Number 02484072 02484072
Brand name MAR-DILTIAZEM CD MAR-DILTIAZEM CD
Common or Proper name DILTIAZEM CD DILTIAZEM CD
Company Name MARCAN PHARMACEUTICALS INC MARCAN PHARMACEUTICALS INC
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG 180MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 100 Tablet 100 Tablet
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Delay in shipping of the drug.
Anticipated start date 2020-09-01 2020-08-18
Actual start date 2020-09-08
Estimated end date 2021-11-15 2020-08-30
Actual end date 2022-03-10
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments